Almoosa Health (4018.SR) Earnings Analysis
Almoosa Health (4018.SR) next reports earnings on 2026-08-03, consensus EPS 1.26 SAR. Last quarter (2026-03-11) it beat with EPS 1.85 SAR vs 1.38 SAR est (+34.1%). It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E 24.87.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4018.SR next report earnings?
| Next earnings date | 2026-08-03 |
|---|---|
| Consensus EPS estimate | 1.26 SAR |
| Revenue estimate | 0.39B |
4018.SR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-11 | 1.85 SAR | 1.38 SAR | +34.1% | Beat |
| 2025-11-02 | 1.17 SAR | n/a | n/a | n/a |
Beat rate: 1/1 (100%) over reported quarters with consensus data.
4018.SR valuation and analyst view
| Trailing P/E | 24.87 |
|---|---|
| Trailing EPS | 4.712 SAR |
| Price / book | 2.69 |
| Dividend yield | 1.11% |
| Market cap | 5.18B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Almoosa Health (4018.SR)'s next earnings date?
Almoosa Health is next scheduled to report on 2026-08-03, with a consensus EPS estimate of 1.26 SAR and revenue estimate of 0.39B.
Did 4018.SR beat earnings last quarter?
In its 2026-03-11 report, 4018.SR posted EPS of 1.85 SAR versus a 1.38 SAR estimate — a beat of 34.1%.
What is 4018.SR's earnings track record?
Over the last 1 reported quarters with consensus data, 4018.SR beat estimates 1 times (100%).
What is 4018.SR's current P/E ratio and EPS?
4018.SR trades at a trailing P/E of 24.87 on trailing EPS of 4.711617749210645 SAR.
What do analysts rate 4018.SR?
4018.SR has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.